Plain-English translation of NCT06197165 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether Shiatsu—a form of Japanese massage therapy—can help relieve symptoms in people with cardiac amyloidosis, a serious condition where abnormal proteins build up in the heart. The study will compare two types of Shiatsu (one designed specifically for amyloidosis symptoms and one general comfort massage) against no treatment, to see which approach works best and how it affects quality of life.
Amyloidosis causes widespread pain, fatigue, sleep problems, anxiety, and other disabling symptoms that significantly impact daily life. Current medical treatments address the disease itself, but research suggests that complementary therapies like Shiatsu may help manage these difficult symptoms and improve overall well-being.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of three groups: targeted Shiatsu sessions, comfort Shiatsu sessions, or no Shiatsu (control group). You will receive Shiatsu massage sessions at the hospital and be asked to complete questionnaires about your symptoms, sleep, pain, anxiety, and overall quality of life before and after the sessions. The study will also measure some physical responses like heart rate and blood pressure to see how Shiatsu affects your body.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France